-
11.
公开(公告)号:US20230096557A1
公开(公告)日:2023-03-30
申请号:US17737880
申请日:2022-05-05
Applicant: Cepheid
Inventor: Russell Higuchi
IPC: C12N15/11 , C12Q1/6876 , C12P19/34
Abstract: Described herein are methods and compositions that provide highly efficient nucleic acid amplification. In some embodiments, this allows a 3-fold or greater increase of amplification product for each amplification cycle and therefore increased sensitivity and speed over conventional PCR. Modified bases can be employed in primers to provide this base-3 or greater amplification with satisfactory PCR cycle times, which are improved, as compared to those observed in the absence of modified bases.
-
公开(公告)号:US20220226809A1
公开(公告)日:2022-07-21
申请号:US17586645
申请日:2022-01-27
Applicant: Cepheid
Inventor: Edwin Wei-Lung Lai , Andrew Kohlway , Reuel Van Atta , Russell Higuchi , Alexander A. Gall , Kriszten Kocmond
IPC: B01L3/00 , B01L7/00 , C12Q1/6827 , C12N15/10 , C12Q1/6853 , C12Q1/686
Abstract: Methods of determining methylation of DNA are provided. In one illustrative, but non-limiting embodiment the method comprises i) contacting a biological sample comprising a nucleic acid to a first matrix material comprising a first column or filter where said matrix material binds and/or filters nucleic acids in said sample and thereby purifies the DNA; ii) eluting the bound DNA from the first matrix material and denaturing the DNA to produce eluted denatured DNA; iii) heating the eluted DNA in the presence of bisulfite ions to produce a deaminated nucleic acid; iv) contacting said deaminated nucleic acid to a second matrix material comprising a second column to bind said deaminated nucleic acid to said second matrix material; v) desulphonating the bound deaminated nucleic acid and/or simultaneously eluting and desulphonating the nucleic acid by contacting the deaminated nucleic acid with an alkaline solution to produce a bisulfite converted nucleic acid; vi) eluting said bisulfite converted nucleic acid from said second matrix material; and vii) performing methylation specific PCR and/or nucleic acid sequencing, and/or high resolution melting analysis (HRM) on said bisulfite-converted nucleic acid to determine the methylation of said nucleic acid, wherein at least steps iv) through vi) are performed in a single reaction cartridge.
-
公开(公告)号:US20190382847A1
公开(公告)日:2019-12-19
申请号:US16411485
申请日:2019-05-14
Applicant: Cepheid
Inventor: Leena McCann , Stacey Ellen Wallace , Edwin Wei-Lung Lai , Russell Higuchi
IPC: C12Q1/6886
Abstract: Compositions and methods for detecting bladder cancer are provided. In some embodiments, methods of detecting low grade bladder cancer are provided. In some embodiments, methods of monitoring recurrence of bladder cancer are provided. In some embodiments, the methods comprise detecting androgen receptor (AR) and/or uroplakin 1B (UPK1B).
-
公开(公告)号:US10329622B2
公开(公告)日:2019-06-25
申请号:US14199292
申请日:2014-03-06
Applicant: Cepheid
Inventor: Leena McCann , Stacey Ellen Wallace , Edwin Wei-Lung Lai , Russell Higuchi
IPC: C12Q1/6886
Abstract: Compositions and methods for detecting bladder cancer are provided. In some embodiments, methods of detecting low grade bladder cancer are provided. In some embodiments, methods of monitoring recurrence of bladder cancer are provided. In some embodiments, the methods comprise detecting androgen receptor (AR) and/or uroplakin 1B (UPK1B).
-
公开(公告)号:US20250084483A1
公开(公告)日:2025-03-13
申请号:US18680611
申请日:2024-05-31
Applicant: Cepheid
Inventor: Leena McCann , Stacey Ellen Wallace , Edwin Wei-Lung Lai , Russell Higuchi
IPC: C12Q1/6886
Abstract: Compositions and methods for detecting bladder cancer are provided. In some embodiments, methods of detecting low grade bladder cancer are provided. In some embodiments, methods of monitoring recurrence of bladder cancer are provided. In some embodiments, the methods comprise detecting androgen receptor (AR) and/or uroplakin 1B (UPK1B).
-
公开(公告)号:US11603555B2
公开(公告)日:2023-03-14
申请号:US15182394
申请日:2016-06-14
Applicant: Cepheid
Inventor: Edwin W. Lai , Andrew Kohlway , Reuel Vanatta , Russell Higuchi , Alexander Gall , Kriszten Kocmond
IPC: C12Q1/6806 , C12Q1/6827 , C12Q1/6886 , C12N15/10 , B01L7/00
Abstract: In various embodiments methods of determining methylation of DNA are provided. In one illustrative, but non-limiting embodiment the method comprises i) contacting a biological sample comprising a nucleic acid to a first matrix material comprising a first column or filter where said matrix material binds and/or filters nucleic acids in said sample and thereby purifies the DNA; ii) eluting the bound DNA from the first matrix material and denaturing the DNA to produce eluted denatured DNA; iii) heating the eluted DNA in the presence of bisulfite ions to produce a deaminated nucleic acid; iv) contacting said deaminated nucleic acid to a second matrix material comprising a second column to bind said deaminated nucleic acid to said second matrix material; v) desulfonating the bound deaminated nucleic acid and/or simultaneously eluting and desulfonating the nucleic acid by contacting the deaminated nucleic acid with an alkaline solution to produce a bisulfite converted nucleic acid; vi) eluting said bisulfite converted nucleic acid from said second matrix material; and vii) performing methylation specific PCR and/or nucleic acid sequencing, and/or high resolution melting analysis (HRM) on said bisulfite-converted nucleic acid to determine the methylation of said nucleic acid, wherein at least steps iv) through vi) are performed in a single reaction cartridge.
-
公开(公告)号:US20150133325A1
公开(公告)日:2015-05-14
申请号:US14394352
申请日:2013-04-19
Applicant: Cepheid
Inventor: Russell Higuchi , Stacey Ellen Wallace , Edwin Wei-Lung Lai
IPC: C12Q1/68
CPC classification number: C12Q1/6886 , C12Q2600/158 , C12Q2600/16 , C12Q2600/166
Abstract: Compositions and methods for detecting bladder cancer are provided. In some embodiments, methods of monitoring recurrence of bladder cancer are provided. In some embodiments, the methods comprise detecting a set of markers consisting of CRH, IGF2, KRT20, and ANXA10.
Abstract translation: 提供了检测膀胱癌的组合物和方法。 在一些实施方案中,提供了监测膀胱癌复发的方法。 在一些实施方案中,所述方法包括检测由CRH,IGF2,KRT20和ANXA10组成的一组标志物。
-
公开(公告)号:US20140309127A1
公开(公告)日:2014-10-16
申请号:US14199292
申请日:2014-03-06
Applicant: Cepheid
Inventor: Leena McCann , Stacey Ellen Wallace , Edwin Wei-Lung Lai , Russell Higuchi
IPC: C12Q1/68
CPC classification number: C12Q1/6886 , C12Q2600/106 , C12Q2600/158
Abstract: Compositions and methods for detecting bladder cancer are provided. In some embodiments, methods of detecting low grade bladder cancer are provided. In some embodiments, methods of monitoring recurrence of bladder cancer are provided. In some embodiments, the methods comprise detecting androgen receptor (AR) and/or uroplakin 1B (UPK1B).
Abstract translation: 提供了检测膀胱癌的组合物和方法。 在一些实施方案中,提供了检测低级膀胱癌的方法。 在一些实施方案中,提供了监测膀胱癌复发的方法。 在一些实施方案中,所述方法包括检测雄激素受体(AR)和/或乌普拉汀1B(UPK1B)。
-
公开(公告)号:US20240141415A1
公开(公告)日:2024-05-02
申请号:US18095982
申请日:2023-01-11
Applicant: Cepheid
Inventor: Edwin Wei-Lung Lai , Andrew Kohlway , Reuel Van Atta , Russell Higuchi , Alexander A. Gall , Kriszten Kocmond
IPC: C12Q1/6827 , B01L7/00 , C12N15/10 , C12Q1/6806 , C12Q1/6886
CPC classification number: C12Q1/6827 , B01L7/52 , C12N15/1006 , C12N15/1017 , C12Q1/6806 , C12Q1/6886 , B01L2300/0864 , B01L2300/087 , C12Q2600/154
Abstract: In various embodiments methods of determining methylation of DNA are provided. In one illustrative, but non-limiting embodiment the method comprises i) contacting a biological sample comprising a nucleic acid to a first matrix material comprising a first column or filter where said matrix material binds and/or filters nucleic acids in said sample and thereby purifies the DNA; ii) eluting the bound DNA from the first matrix material and denaturing the DNA to produce eluted denatured DNA; iii) heating the eluted DNA in the presence of bisulfite ions to produce a deaminated nucleic acid; iv) contacting said deaminated nucleic acid to a second matrix material comprising a second column to bind said deaminated nucleic acid to said second matrix material; v) desulfonating the bound deaminated nucleic acid and/or simultaneously eluting and desulfonating the nucleic acid by contacting the deaminated nucleic acid with an alkaline solution to produce a bisulfite converted nucleic acid; vi) eluting said bisulfite converted nucleic acid from said second matrix material; and vii) performing methylation specific PCR and/or nucleic acid sequencing, and/or high resolution melting analysis (HRM) on said bisulfite-converted nucleic acid to determine the methylation of said nucleic acid, wherein at least steps iv) through vi) are performed in a single reaction cartridge.
-
公开(公告)号:US20230167490A1
公开(公告)日:2023-06-01
申请号:US17921582
申请日:2021-04-27
Applicant: Cepheid
Inventor: Russell Higuchi , Nicholas Wang
IPC: C12Q1/6855 , C12Q1/6806 , C12Q1/6832 , C12Q1/6876
CPC classification number: C12Q1/6855 , C12Q1/6806 , C12Q1/6832 , C12Q1/6876
Abstract: Described herein are methods and compositions that make use of pseudo-complementary bases to reduce unwanted hybridization in assays to detect and/or quantify particular nucleotide sequences, as well as in nucleic acid sequencing protocols.
-
-
-
-
-
-
-
-
-